/RSHUF
RSHUF Stock - Respiri Limited
Healthcare|Medical - DevicesOTC
$0.06+0.00%
+$0.00 (+0.00%) • May 6
75
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.80
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.06
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for RSHUF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.06 – $0.06
TARGET (TP)$0.07
STOP LOSS$0.05
RISK/REWARD1:1.5
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-0.44
52W High$0.06
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $456,914 | $70,533 | $253,688 | $270,074 | $2.16M |
| Gross Profit | $453,057 | $4,930 | $-5,604 | $-993,378 | $2.14M |
| Gross Margin | 99.2% | 7.0% | -2.2% | -367.8% | 99.5% |
| Operating Income | $-7,645,835 | $-5,760,290 | $-7,072,857 | $-12,161,920 | $-9,462,636 |
| Net Income | $-7,129,247 | $-5,775,290 | $-6,624,313 | $-11,040,347 | $-7,260,935 |
| Net Margin | -1560.3% | -8188.1% | -2611.2% | -4087.9% | -336.9% |
| EPS | $-0.01 | $-0.01 | $-0.01 | $-0.02 | $-0.01 |
Company Overview
Respiri Limited, an e-health SaaS company, researches, develops, and commercializes medical devices in Australia. The company develops, produces, and sells mobile health applications. Its products include wheezo, an electronic wheeze detection tool to detect wheeze in children; respiri mobile application; and Respiri health portal. The company was formerly known as iSonea Limited and changed its name to Respiri Limited in December 2015. Respiri Limited is based in Melbourne, Australia.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
RSHUFBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q1 2025
EPS Surprise History
Q4 21
No data
Q2 22
No data
Q3 22
No data
Q1 23
No data
Q2 23
No data
Q2 24
No data
Q4 24
No data
Q1 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2025 | Aug 26, 2025 | — | — | — | — |
Q1 2025 | Feb 26, 2025 | — | $-0.00 | — | — |
Q4 2024 | Oct 23, 2024 | — | $-0.00 | — | — |
Q2 2024 | May 9, 2024 | — | $-0.00 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.00 | — | — |
Q1 2023 | Feb 27, 2023 | — | $-0.00 | — | — |
Q3 2022 | Aug 30, 2022 | — | $-0.00 | — | — |
Q2 2022 | Apr 30, 2022 | — | $-0.00 | — | — |
Q4 2021 | Oct 30, 2021 | — | $-0.00 | — | — |
Q2 2021 | Apr 30, 2021 | — | $-0.01 | — | — |
Q4 2020 | Oct 30, 2020 | — | $-0.01 | — | — |
Q4 2019 | Dec 31, 2019 | — | $-0.00 | — | — |
Q2 2019 | Jun 30, 2019 | — | $-0.01 | — | — |
Q4 2018 | Dec 31, 2018 | — | $-0.01 | — | — |
Q2 2018 | Jun 30, 2018 | — | $-0.00 | — | — |
Q4 2017 | Dec 31, 2017 | — | $-0.00 | — | — |
Q3 2017 | Jul 30, 2017 | — | $-0.00 | — | — |
Q2 2017 | Apr 30, 2017 | — | $-0.00 | — | — |
Q3 2016 | Jul 30, 2016 | — | $-0.00 | — | — |
Q2 2016 | Apr 30, 2016 | — | $-0.01 | — | — |
Latest News
Loading news...
Frequently Asked Questions about RSHUF
What is RSHUF's current stock price?
Respiri Limited (RSHUF) is currently trading at $0.06 per share. The stock has moved +0.00% today.
What is the analyst price target for RSHUF?
No analyst price targets are currently available for this stock.
What sector is Respiri Limited in?
Respiri Limited operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the OTC exchange.
What is RSHUF's market cap?
Respiri Limited has a market capitalization of $0.09 billion, making it a small-cap company.
Does RSHUF pay dividends?
No, Respiri Limited does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorADOIF
Adocia S.A.
$8.87
Mkt Cap: $0.1B
AMEUF
Anteris Technologies Ltd
$5.70
Mkt Cap: $0.1B
CKMTF
Carmat S.A.
$12.75
Mkt Cap: $0.1B
CNVCF
BioHarvest Sciences Inc.
$6.30
Mkt Cap: $0.1B
CSAMF
CSAM Health Group AS
$4.82
Mkt Cap: $0.1B
EOFBY
Ecofibre Limited
$0.84
Mkt Cap: $0.1B
ETXPF
E-therapeutics Plc
$0.13
Mkt Cap: $0.1B
JMDMF
Japan Medical Dynamic Marketing, Inc.
$3.01
Mkt Cap: $0.1B
MCURF
Mind Cure Health Inc.
$0.51
Mkt Cap: $0.1B
RTGN
RetinalGenix Technologies Inc.
$3.20
Mkt Cap: $0.1B
Explore stocks similar to RSHUF for comparison